Natera Shares Soar Over 20% To All Time High, Bolstering Co Founder’s Billionaire Status Natera's latest earnings report has propelled its shares to an all time high, pushing co founder Matthew Rabinowitz's net worth above $1.
5 billion. The company's cancer detecting blood test, Signatera, reported "blowout volume" in the second quarter, a testament to growing demand for cancer diagnosis and treatment solutions.
Natera's revenue has surged dramatically over the past decade, from annual figures in the low hundreds of millions to $2. 3 billion in 2022.